Higher C‐ets‐1 and lower miR‐128‐3p expression levels intensify MET signaling and thereby suggest TGFβ1 as a regulator of HGF‐mediated migration in MCF10A and breast cancer cells. The gene discussed is MET; the disease is breast carcinoma.